Glenmede Trust’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-83,266
| Closed | -$2.12M | – | 1432 |
|
|
2024
Q4 | $2.12M | Buy |
83,266
+33,687
| +68% | +$859K | 0.01% | 540 |
|
|
2024
Q3 | $1.4M | Sell |
49,579
-198,419
| -80% | -$5.61M | 0.01% | 638 |
|
|
2024
Q2 | $6.54M | Sell |
247,998
-156,381
| -39% | -$4.12M | 0.03% | 410 |
|
|
2024
Q1 | $12.3M | Buy |
404,379
+221,182
| +121% | +$6.72M | 0.06% | 329 |
|
|
2023
Q4 | $5.15M | Sell |
183,197
-318,483
| -63% | -$8.95M | 0.03% | 424 |
|
|
2023
Q3 | $13.6M | Buy |
501,680
+465,063
| +1,270% | +$12.6M | 0.08% | 264 |
|
|
2023
Q2 | $1.32M | Hold |
36,617
| – | – | 0.01% | 591 |
|
|
2023
Q1 | $1.32M | Buy |
36,617
+971
| +3% | +$35K | 0.01% | 592 |
|
|
2022
Q4 | $1.41M | Buy |
35,646
+5,410
| +18% | +$214K | 0.01% | 585 |
|
|
2022
Q3 | $1.21M | Buy |
+30,236
| New | +$1.21M | 0.01% | 605 |
|
|
2022
Q2 | – | Sell |
-17,761
| Closed | -$691K | – | 1360 |
|
|
2022
Q1 | $691K | Buy |
+17,761
| New | +$691K | ﹤0.01% | 813 |
|
|
2021
Q4 | – | Sell |
-21,108
| Closed | -$762K | – | 1364 |
|
|
2021
Q3 | $762K | Sell |
21,108
-1,258
| -6% | -$45.4K | ﹤0.01% | 778 |
|
|
2021
Q2 | $916K | Sell |
22,366
-7,512
| -25% | -$308K | ﹤0.01% | 726 |
|
|
2021
Q1 | $1.3M | Buy |
29,878
+7,518
| +34% | +$328K | 0.01% | 620 |
|
|
2020
Q4 | $1.12M | Buy |
+22,360
| New | +$1.12M | 0.01% | 633 |
|